Clinical trials recruiting for Neoplasms
28
Recruiting trials
21
US states with sites
19
Countries
29%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Michigan | 4 |
| Tennessee | 4 |
| California | 3 |
| Florida | 3 |
| Ohio | 3 |
| Pennsylvania | 3 |
| Texas | 3 |
| Colorado | 2 |
| Georgia | 2 |
| Maryland | 2 |
| Massachusetts | 2 |
| New York | 2 |
Top cities
Detroit, Michigan 4Houston, Texas 3Miami, Florida 3Nashville, Tennessee 3Bethesda, Maryland 2Boston, Massachusetts 2Los Angeles, California 2Pittsburgh, Pennsylvania 2San Antonio, Texas 2Atlanta, Georgia 1
Self-screener
Recruiting trials
- 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
- 68Ga-P3 PET/CT Imaging in Prostate
- A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
- A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer
- A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- Anatomical-Clinical Base of Adenocarcinoma Pancreatic
- Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
- Biennial CEM in Women With a Personal History of Breast Cancer
- Cancer Experience Registry (CER) for Cancer Patients and Caregivers
- Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
- Early Intervention Strategies for Lung Cancer
- HTL0039732 in Participants With Advanced Solid Tumours
- Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer
- ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
- Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and Monitoring in Colombia
- OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.
- Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors
- RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
- Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors
- Screening Strategies Among High-risk Populations for Anal Cancer
- Spanish Series of Patients Treated With the Radionuclide Lutetium177
- Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- The GEOLynch Cohort Study
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia
- Variation in Drug Interactions in People With HIV (PLWH) Aged 60 Years and Older.
Related conditions
Trials recruiting for Neoplasms often also study these conditions. Each links to its own recruiting-trial list.
Colorectal cancer 1359Prostate cancer 1234Lung cancer 2180Pancreatic cancer 870Breast cancer 2239Neoplasms by Site 11Lung Neoplasms 33Stomach Neoplasms 11Pancreatic Neoplasms 38Colorectal Neoplasms 61
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Neoplasms trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.